Outlook Therapeutics, Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2015 Sep2016 Sep2017 Sep2018 Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024
Operating Activities
Net Income -48.67M-53.30M-38.85M-30.09M-34.52M-35.24M-53.16M-66.05M-58.98M-75.37M
Depreciation and Depletion 0.22M0.16M0.16M
Share-based Compensation 11.18M12.45M8.57M1.99M1.31M2.81M4.89M7.71M5.55M5.39M
Gains from Sales and Divestitures 0.11M0.00M
Gains from Investment Securities 2.60M0.10M-3.16M0.21M1.45M0.22M0.45M-0.47M0.21M-38.64M
Asset Writedowns and Impairment 11.30M0.53M
Non-cash Items 2.49M
Cash from Operations -27.48M-45.48M-15.51M-33.04M-32.29M-31.79M-54.25M-56.67M-42.97M-68.79M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.01M0.01M4.01M1.32M1.31M0.24M0.89M1.66M2.53M2.68M
Depreciation & Amortization (CF) 1.82M2.39M2.69M3.05M3.36M0.55M0.26M0.20M0.04M0.11M
Change in Working Capital
Change in Receivables 0.02M-0.02M
Change in Account Payables 6.58M-5.33M5.73M-6.71M-1.33M-1.49M-0.20M1.30M3.08M1.39M
Change in Accured Expenses 2.24M1.15M0.89M-1.66M-0.48M0.73M-5.30M0.16M-0.71M0.49M
Change in Taxes 0.19M0.10M0.50M-0.50M0.00M-0.00M
Other Working Capital Changes 1.02M-1.98M-2.61M-3.06M0.02M0.31M1.73M3.09M-2.62M4.90M
Investing Activities
Capital Expenditures 8.80M1.10M0.29M2.78M0.44M
Cash from Investing Activities -8.80M-1.10M-0.29M-2.78M-0.44M-0.90M
Financing Activities
Other financing activities -0.00M0.22M1.09M0.01M0.60M0.82M
Cash from Financing Activities 43.00M39.86M16.63M34.35M39.03M37.21M56.19M59.59M48.97M60.33M
Additional items
Change in Cash 6.72M-6.72M0.83M-1.47M6.30M4.52M1.94M2.92M6.00M-8.46M
Beginning Cash Balance 3.61M
Free Cash Flow -36.28M-46.58M-15.80M-35.82M-32.73M-31.79M-54.25M-56.67M-42.97M-68.79M
Net Cash Flow 6.72M-6.72M0.83M-1.47M6.30M4.52M1.94M2.92M6.00M-8.46M